ALT5 Sigma (AIFC) Stock Price, News & Analysis

Company Overview

ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Recycling segment is involved in a turnkey appliance recycling program. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.

Key Stats

• Today's Range: $0.63 to $0.73
• 50-Day Range: $0.64 to $1.32
• 52-Week Range: $0.63 to $10.95
• Volume: 2.26 million shs
• Average Volume: 1.46 million shs
• Market Capitalization: $88.90 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

ALT5 Sigma Stock Analysis - MarketRank™

ALT5 Sigma scored higher than 2% of companies evaluated by MarketBeat, and ranked 879th out of 884 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.5 / 5
• Analyst Rating: Sell

Consensus Rating

ALT5 Sigma has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

ALT5 Sigma has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

ALT5 Sigma has a P/B Ratio of 0.07. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

10.74% of the float of ALT5 Sigma has been sold short.

Short Interest Ratio / Days to Cover

ALT5 Sigma has a short interest ratio ("days to cover") of 5.77.

Change versus previous month

Short interest in ALT5 Sigma has recently decreased by 4.11%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

ALT5 Sigma does not currently pay a dividend.

Dividend Growth

ALT5 Sigma does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

MarketBeat Follows

3 people have added ALT5 Sigma to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, ALT5 Sigma insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.21% of the stock of ALT5 Sigma is held by insiders.

Percentage Held by Institutions

6.27% of the stock of ALT5 Sigma is held by institutions.

Company Calendar

• Last Earnings: 5/18/2026
• Today: 6/06/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: FIN - MISC SVCS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:AIFC
• Previous Symbol: NASDAQ:ALTS
• CIK: 862861
• Web: N/A
• Phone: 702-997-5968
• Fax: 952-930-1800
• Employees: 170
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$344.51 million
• Net Margins: -2,483.94%
• Pretax Margin: -3,169.40%
• Return on Equity: -68.25%
• Return on Assets: -62.43%

Debt

• Debt-to-Equity Ratio: 0.03
• Current Ratio: 0.82
• Quick Ratio: 0.82

Sales & Book Value

• Annual Sales: $24.84 million
• Price / Sales: 3.58
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $9.07 per share
• Price / Book: 0.07

Miscellaneous

• Outstanding Shares: 139,840,000
• Free Float: 139,543,000
• Market Cap: $88.90 million
• Optionable: N/A
• Beta: 1.71